Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4565598 | 0.89 | ENPEP (0.43) | ENPEPLMNAALDH1A1TSHRTHRB | |
| SCHEMBL13225821 | 0.83 | ENPEP (0.40) | ENPEPALDH1A1THRBRECQLTDP1 | |
| SCHEMBL9586717 | 0.78 | RNPEP (0.38) | ENPEPALDH1A1THRBRECQLTDP1 | |
| SCHEMBL28674149 | 0.78 | ALDH1A1 (0.47) | ENPEPLMNAALDH1A1TSHRTHRB | |
| SCHEMBL30019003 | 0.78 | TP53 (0.44) | ENPEPALDH1A1RNPEPSLC7A5TP53 | |
| SCHEMBL27404117 | 0.78 | ENPEP (0.70) | ENPEPALDH1A1SLC7A5ALOX15KMT2A | |
| SCHEMBL1200181 | 0.78 | RNPEP (0.57) | LMNAALDH1A1RNPEPSLC7A5TP53 | |
| SCHEMBL28741357 | 0.76 | MME (0.47) | ENPEPKMT2A | |
| SCHEMBL19815050 | 0.75 | TP53 (0.50) | ENPEPLMNATSHRTDP1OR51E2 | |
| SCHEMBL148584 | 0.75 | SLC7A5 (0.62) | ENPEPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1986 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025223955-A1 | METHOD FOR PRODUCING POLYASPARTIC ACID, POLYASPARTIC ACID AND ITS USE | BASF SE (DE) | 2025-10-30 | — | — | WO | claimed |
| CN-114191548-A | Tumor microenvironment responsive nano-assembly and application thereof in tumor combined treatment | 三峡大学 | 2022-03-18 | — | — | CN | claimed |
| US-10092500-B2 | Oral care compositions | BASF SE (DE) | 2018-10-09 | — | — | US | claimed |
| US-20170283680-A1 | EMULSIFIERS FOR INVERT EMULSION WELLBORE FLUIDS AND METHODS OF USE THEREOF | M-I L.L.C. | 2017-10-05 | — | — | US | claimed |
| WO-2017173010-A1 | EMULSIFIERS FOR INVERT EMULSION WELLBORE FLUIDS AND METHODS OF USE THEREOF | M-I L.L.C. (US) | 2017-10-05 | — | — | WO | claimed |
| US-20170216191-A1 | ORAL CARE COMPOSITIONS | BASF SE (DE) | 2017-08-03 | — | — | US | claimed |
| US-20170143612-A1 | ORAL CARE COMPOSITIONS | BASF SE (DE) | 2017-05-25 | — | — | US | claimed |
| EP-3128998-A1 | ORAL CARE COMPOSITIONS | BASF SE (DE) | 2017-02-15 | — | — | EP | claimed |
| EP-3128992-A1 | ORAL CARE COMPOSITIONS | BASF SE (DE) | 2017-02-15 | — | — | EP | claimed |
| EP-2969954-A1 | SYNTHETIC ZINC HECTORITE VIA HYDROTHERMAL PREPARATION | BASF SE (DE) | 2016-01-20 | — | — | EP | claimed |
| WO-2014164624-A1 | SYNTHETIC ZINC PHLOGOPITE VIA HYDROTHERMAL PREPARATION | BASF SE (DE) | 2014-10-09 | — | — | WO | claimed |
| WO-2014164632-A1 | SYNTHETIC ZINC HECTORITE VIA HYDROTHERMAL PREPARATION | BASF SE (DE) | 2014-10-09 | — | — | WO | claimed |
| WO-2014164629-A1 | SYNTHETIC MEGAKALSILITE VIA HYDROTHERMAL PREPARATION | BASF SE (DE) | 2014-10-09 | — | — | WO | claimed |
| US-20140251202-A1 | Synthetic Zinc Phlogopite via Hydrothermal Preparation | BASF SE (DE) | 2014-09-11 | — | — | US | claimed |
| US-20140256866-A1 | Synthetic Megakalsilite via Hydrothermal Preparation | BASF SE (DE) | 2014-09-11 | — | — | US | claimed |
| US-20100204432-A1 | BIODEGRADABLE ELASTOMERS PREPARED BY THE CONDENSATION OF AN ORGANIC DI-, TRI- OR TETRA-CARBOXYLIC ACID AND AN ORGANIC DIOL | YOUNES HUSAM | 2010-08-12 | — | — | US | claimed |
| WO-2008144881-A1 | BIODEGRADABLE ELASTOMERS PREPARED BY THE CONDENSATION OF AN ORGANIC DI-, TRI- OR TETRA-CARBOXYLIC ACID AND AN ORGANIC DIOL | GENESIS GROUP INC. (CA) | 2008-12-04 | — | — | WO | claimed |
| US-20030130135-A1 | Emulsifier for oil-based drilling fluids | CROMPTON CORPORATION | 2003-07-10 | — | — | US | claimed |
| EP-0799887-B1 | Fabric softener compositions | PROCTER & GAMBLE (US) | 2003-06-11 | — | — | EP | claimed |
| WO-2003042324-A1 | EMULSIFIER FOR OIL-BASED DRILLING FLUIDS | AKZO NOBEL INDUSTRIAL SPECIALTIES INC. (US) | 2003-05-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170143612-A1 | ORAL CARE COMPOSITIONS | ARG1, ARGLU1, HDAC1 | ENPEP 1930/4885LMNA 2622/4885ALDH1A1 4352/4885 |
| US-20170216191-A1 | ORAL CARE COMPOSITIONS | ARG1, ARGLU1, IDUA | ENPEP 1366/4885LMNA 3220/4885ALDH1A1 3604/4885 |
| US-10092500-B2 | Oral care compositions | ARG1, ARGLU1, IDUA | ENPEP 1366/4885LMNA 3220/4885ALDH1A1 3604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.